Observational studyCalcified tissue international2023
Comment on One-Year Romosozumab Treatment Followed by One-Year Denosumab Treatment for Osteoporosis in Patients on Hemodialysis: An Observational Study.
Masatomo Ogata et al.PubMed ↗Publisher ↗
No numbers read from the abstract.